Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

China flag China · Delayed Price · Currency is CNY
11.25
-0.14 (-1.23%)
Mar 19, 2026, 12:14 PM CST
Market Cap15.20B +11.7%
Revenue (ttm)5.38B -1.0%
Net Income420.20M
EPS0.29
Shares Out1.47B
PE Ratio39.84
Forward PE19.47
Dividend0.25 (2.19%)
Ex-Dividend Daten/a
Volume1,734,400
Average Volume3,677,074
Open11.40
Previous Close11.39
Day's Range11.20 - 11.40
52-Week Range9.72 - 14.34
Beta0.45
RSI37.98
Earnings DateMar 30, 2026

About SHE:002399

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. provides pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates in four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization (CDMO), and Others. The company offers finished dose pharmaceutical products, such as prolongin, inhixa, neoparin, and heparin and enoxaparin sodium injections; API products, including heparin and enoxaparin sodium APIs; and pan... [Read more]

Sector Healthcare
Founded 1998
Employees 1,926
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002399
Full Company Profile

Financial Performance

Financial Statements